Johnson & Johnson JNJ Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $21.69B-43.6% | $19.71B-18.2% | $18.23B-8.8% | $18.58B-25.3% | $38.47B+51.0% | ||
| $363M+18.2% | $393M-5.8% | $331M+4.4% | $303M-49.2% | $307M-58.8% | ||
| $17.72B+10.6% | $17.18B+15.7% | $17.61B+8.9% | $17.85B+13.0% | $16.02B+7.2% | ||
| $14.58B+15.2% | $14.19B+14.0% | $14.15B+12.2% | $13.41B+10.2% | $12.66B+11.2% | ||
| $4.82B+17.8% | $4.15B+1.7% | $4.29B+2.8% | $4.36B-0.4% | $4.09B-8.2% | ||
| $59.17B-17.3% | $55.62B-0.5% | $54.61B+2.6% | $54.5B-5.7% | $71.55B+25.5% | ||
| $23.27B+11.5% | $23.17B+12.9% | $22.34B+9.1% | $21.95B+11.1% | $20.87B+6.3% | ||
| $31.43B+8.3% | $31.2B+10.4% | $31.04B+7.8% | $30.52B+7.9% | $29.01B+3.8% | ||
| $48.56B+9.2% | $48.77B+10.3% | $48.05B+7.3% | $48.12B+8.7% | $44.47B+21.4% | ||
| $200.89B+3.7% | $199.21B+10.6% | $192.82B+8.1% | $193.39B+6.8% | $193.67B+12.6% | ||
| $10.46B+9.6% | $11.99B+16.3% | $9.63B+7.5% | $9.46B+7.0% | $9.55B+16.8% | ||
| $6.76B-4.1% | $6.96B-4.1% | $6.93B+1.1% | $7.02B+1.5% | $7.05B+0.4% | ||
| $17.46B+25.6% | $8.5B+42.0% | $6.39B+43.1% | $11.53B+17.0% | $13.9B+62.5% | ||
| $17.46B+25.6% | $8.5B+42.0% | $6.39B+43.1% | $11.53B+17.0% | $13.9B+62.5% | ||
| $57.72B+1.4% | $54.13B+7.6% | $50.87B-1.7% | $54.18B+0.5% | $56.9B+16.8% | ||
| $37.53B-2.2% | $39.44B+28.7% | $39.41B+25.9% | $39.24B+24.0% | $38.36B+52.9% | ||
| $10.21B-2.2% | $9.87B-43.8% | $9.93B-33.5% | $10.26B-27.1% | $10.44B-30.7% | ||
| $119.71B+3.6% | $117.67B+8.3% | $113.54B+5.0% | $114.92B+4.9% | $115.56B+13.4% | ||
| $169.16B+4.0% | $168.98B+8.5% | $167.28B+7.8% | $165.37B+6.4% | $162.64B+6.0% | ||
| -$14.83B-26.3% | -$14.93B-27.2% | -$15.24B-21.7% | -$14.31B-27.1% | -$11.74B-9.0% | ||
| $76.26B+0.5% | $75.62B-0.1% | $75.89B+0.4% | $75.71B0.0% | $75.91B+0.3% | ||
| $81.19B+3.9% | $81.54B+14.1% | $79.28B+13.0% | $78.47B+9.7% | $78.11B+11.6% | ||
| $200.89B+3.7% | $199.21B+10.6% | $192.82B+8.1% | $193.39B+6.8% | $193.67B+12.6% | ||
| $363M+18.2% | $393M-5.8% | $331M+4.4% | $303M-49.2% | $307M-58.8% | ||
| $6.73B-20.8% | $6.87B-34.3% | $6.67B-28.7% | $6.8B-24.5% | $8.49B-17.6% | ||
| $49.06B+33.5% | $50.4B+34.0% | $48.74B+23.4% | $49.84B+25.4% | $36.76B+7.2% | ||
| $14.11B+22.3% | $14.37B+25.9% | $12.42B+13.7% | $12.19B+15.6% | $11.53B-18.3% | ||
| $54.7B+9.6% | $54.36B+11.5% | $53.38B+8.3% | $52.47B+9.2% | $49.88B+4.8% | ||
| $14.11B+22.3% | $14.37B+25.9% | $12.42B+13.7% | $12.19B+15.6% | $11.53B-18.3% | ||
| $2.91B+14.1% | $4.53B+9.9% | $3.97B+9.7% | $3.3B+16.0% | $2.55B+17.1% | ||
| $7.4B-6.5% | $8.59B+0.5% | $7.6B-33.6% | $7.4B-29.7% | $7.91B-23.3% | ||
| $1.09B-74.2% | $1.39B-63.2% | $1.93B-60.1% | $1.67B-61.4% | $4.22B+27.1% | ||
| $7.4B-6.5% | $8.59B+0.5% | $7.6B-33.6% | $7.4B-29.7% | $7.91B-23.3% | ||
| $18.4B-2.0% | $19.12B+8.8% | $21.36B+15.8% | $20.82B+18.7% | $18.78B+16.1% | ||
| $2.91B+14.1% | $4.53B+9.9% | $3.97B+9.7% | $3.3B+16.0% | $2.55B+17.1% | ||
| $3.12B0.0% | $3.12B0.0% | $3.12B0.0% | $3.12B0.0% | $3.12B0.0% | ||
| $54.7B+9.6% | $54.36B+11.5% | $53.38B+8.3% | $52.47B+9.2% | $49.88B+4.8% | ||
| $486M+23.0% | $486M+24.6% | $418M+18.1% | $418M+22.6% | $395M-86.3% | ||
| $7.01B+189% | $6.79B+177% | $5.99B+103% | $3.8B+44.2% | $2.43B-23.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Johnson & Johnson's total assets?
- Johnson & Johnson (JNJ) holds $200.89B in total assets, up 3.7% year over year.
- How much debt does Johnson & Johnson have?
- Johnson & Johnson carries $55.0B in total debt against $81.2B of shareholders' equity, a debt-to-equity ratio of 0.68.
- How much cash does Johnson & Johnson have?
- Johnson & Johnson holds $21.7B in cash and equivalents.
- Can Johnson & Johnson cover its short-term obligations?
- Its current ratio is 1.03 — current assets exceed current liabilities.
- Where does Johnson & Johnson's balance sheet data come from?
- Every line is extracted from Johnson & Johnson's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
